Skip to main content
TVGN
NASDAQ Life Sciences

Tevogen Q3: $144,713 Cash, Missed Payroll, $28.6M Related-Party Lifeline

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$6.22
Mkt Cap
$40.502M
52W Low
$3.636
52W High
$24.908
52W Position info
71% above low
Off High info
75% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

TVGN sits 71% above its 52-week low of $3.636 on light trading volume (0.4× avg).

Summary

Tevogen reported a $7.0 million Q3 loss with only $144,713 of cash, disclosed missed payroll payments in October and November, and is leaning on a $28.6 million related-party credit line and a $7.0 million grant commitment to fund the next 12 months.


Key Events · Earnings and Guidance · TVGN

  • Q3 Loss With Near-Zero Cash

    Net loss of $7.0 million for the quarter and $18.2 million for nine months, leaving cash of $144,713 at September 30, 2026 versus $552,372 at December 31, 2025.

  • Payroll Missed, Emergency Borrowing

    The company did not make two October 2026 and one November 2026 employee payroll payments when due and submitted a notice of borrowing for $850,000 on November 16, 2026 to pay them and associated payroll taxes.

  • Related-Party Loan Amended and Repaid in Stock

    The October 27, 2026 amendment raised aggregate post-amendment borrowings to $28.6 million, extended the draw window to May 31, 2029, and set a fixed $7.40 per-share repayment price (down from $75.00); on November 2, 2026 the $7.4 million principal plus $177,880 interest was settled with 1,000,000 Principal Shares and 23,733 Interest Shares.

  • Up to 4.99 Million More Shares

    If the full $28.6 million is drawn and repaid in stock at the maximum 7.00% rate, up to approximately 4.99 million additional shares may be issuable, subject to the 9.99% beneficial ownership cap and 19.99% issuance cap.


Analysis · TVGN · Life Sciences

Tevogen closed September with just $144,713 of cash against a $7.0 million quarterly loss, and the filing admits it skipped two October and one November payrolls before borrowing $850,000 on November 16 to catch up. Survival now rests entirely on the Patel Family's amended credit line ($28.6 million available, repayable in stock at a fixed $7.40) and a $7.0 million KRHP grant commitment — both related-party sources. Under the October 27 amendment, the stock repayment price fell from $75.00 to $7.40, meaning future draws convert into far more shares; up to roughly 4.99 million additional shares could be issued if the full facility is drawn and repaid in stock. The company also carries $1.65 million of Polar notes in default since the 2024 merger and repeats a previously disclosed material weakness in internal controls.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TVGN was trading at $6.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $40.5M. The 52-week trading range was $3.64 to $24.91. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TVGN - Latest Insights

TVGN
Nov 04, 2026, 4:38 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $5.72
Real-time Price: $6.22 info
Change: +$0.500 (+9%) info
Market Cap: $40.502M info
TVGN
Oct 08, 2026, 2:35 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $6.05
Real-time Price: $6.22 info
Change: +$0.1698 (+3%) info
Market Cap: $40.502M info
TVGN
Sep 16, 2026, 5:12 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.80
Real-time Price: $6.22 info
Change: -$1.58 (-20%) info
Market Cap: $40.502M info
TVGN
Aug 26, 2026, 3:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.69
Real-time Price: $6.22 info
Change: -$0.470 (-7%) info
Market Cap: $40.502M info
TVGN
Aug 14, 2026, 5:16 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $6.87
Real-time Price: $6.22 info
Change: -$0.650 (-9%) info
Market Cap: $40.502M info